Control of mammary tumor differentiation by SKI-606 (bosutinib)

C-Src is infrequently mutated in human cancers but it mediates oncogenic signals of many activated growth factor receptors and thus remains a key target for cancer therapy. However, the broad function of Src in many cell types and processes requires evaluation of Src-targeted therapeutics within a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Hebbard, Lionel, Cecena, Grace, Golas, Jonathon, Sawada, Junko, Ellies, Lesley G., Charbono, Adriana, Williams, Roy, Jimenez, Rebecca E., Wankell, Miriam, Arndt, Kim T., DeJoy, Susan Q., Rollins, Robert A., Diesl, Veronica, Follettie, Maxmillian, Chen, Lei, Rosfjord, Edward, Cardiff, Robert D., Komatsu, Masanobu, Boschelli, Frank, Oshima, Robert G.
Formato: Texto
Lenguaje:English
Publicado: 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000443/
https://www.ncbi.nlm.nih.gov/pubmed/20818417
http://dx.doi.org/10.1038/onc.2010.412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000443/
https://www.ncbi.nlm.nih.gov/pubmed/20818417
http://dx.doi.org/10.1038/onc.2010.412

Ejemplares similares